Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Search Criteria
Gene/CloneSpeciesStageAnatomy ItemExperimenter
kctd15xenopus ectoderm [+] 

Too many results?Too few results?

Experiment details for kctd15

Takahashi C et al. (2012) Assay

Identification and characterization of Xenopus kctd15, an ectodermal gene repressed by the FGF pathway.

Gene Clone Species Stages Anatomy
kctd15.L image:5440283 laevis NF stage 10.5 ectoderm

  kctd15 (potassium channel tetramerization domain containing 15) gene expression in Xenopus laevis embryo, assayed via in situ hybridization, NF stage 10.5, horizontal view, animal up.

Gene Clone Species Stages Anatomy
kctd15.L image:5440283 laevis NF stage 14 non-neural ectoderm , neural crest
kctd15.L image:5440283 laevis NF stage 16 cranial neural crest , anterior neural ridge , neural crest , preplacodal ectoderm
kctd15.L image:5440283 laevis NF stage 17 cranial neural crest , neural crest
kctd15.L image:5440283 laevis NF stage 18 cranial neural crest , olfactory placode , neural crest
kctd15.L image:5440283 laevis NF stage 25 olfactory placode , trigeminal ganglion , anterior lateral line placode

Display additional annotations [+]
  Fig. 2 Spatial expression of Xenopus kctd15 in early development. Whole mount in situ hybridization against kctd15 was performed on embryos from indicated stages. No detectable signal was seen with the sense probe (data not shown). (A-C) At stage 10.5, kctd15 was uniformly expressed throughout the presumptive ectoderm. (D-G) At stage 14, kctd15 expression was detected in the non-neural ectoderm and was excluded from the neural plate. Dorsal is upward in D and E. Anterior is upward in F and G. (H-J) At stage 16, kctd15 expression was detected in the preplacodal ectoderm (ppe), the neural crest (nc) and the roof plate (rf). Dorsal is upward in H and I. Anterior is upward in J. (K-M) At stage 18, kctd15 expression was detected in the neural crest (nc), the roof plate (rf) and the olfactory placode (pOl). Dorsal is upward in K and L. Anterior is upward in M. (N-P) At stage 25, kctd15 expression was detected in the pronephric duct (pd), the mandibular arch (Md), the hyoid arch (Hy), the olfactory placode (pOl), trigeminal ganglia (tg) and the anterodorsal lateral line placode (pAD). Anterior is left. (Q) Whole mount double in situ hybridization against kctd15 and sox10 was performed on stage 17 embryos (middle and right panels). The right panel is an enlarged view of the middle panel. Dark blue and orange dotted lines mark the kctd15-expressing and sox10-expressing area, respectively. For reference, single in situ hybridization against sox10 (red purple) was also performed (the left panel). All panels are dorsal views with anterior to the top.

Gene Clone Species Stages Anatomy
kctd15.L image:5440283 laevis NF stage 15 cranial neural crest , neural crest

  Fig. 3. FGF signaling inhibits Xenopus kctd15 expression in vivo. (A) FGF represses kctd15 expression indirectly. Animal caps were dissected at stage 10.25, treated with FGF (100 ng/ml) for 3 hours in the presence or absence of cycloheximide (CHX; 5 mg/ml), and then harvested for real-time quantitative RT-PCR analysis. Shown is the average of two independent experiments. The error bar represents SD. Significant differences are marked by asterisks (*p < 0.05, unpaired t test). P values (FGF treatment versus no FGF treatment) were as follows: 0.024 for kctd15 expression in the absence of CHX, 0.80 for kctd15 expression in the presence of CHX, 0.23 for xbra expression in the absence of CHX, and 0.24 for xbra expression in the presence of CHX. (B) Inhibition of FGF signaling increases the abundance of kctd15 mRNA. XFD mRNA (1 ng) was injected into animal poles at 2-cell stage, and injected embryos were harvested at stage 11 for real-time quantitative RT-PCR analysis (left). Embryos were treated with indicated doses of SU5402 at stage 9, and then harvested at stage 11 for real-time quantitative RT-PCR analysis (right). Shown is the average of two (left) or three (right) independent experiments. The error bar represents SD. *P < 0.05, unpaired t test. P values versus control were as follows: 0.14 for XFD mRNA-injected embryos, 0.031 for SU5402 (50 mM)-treated embryos, and 0.015 for SU5402 (100 mM)-treated embryos. (C) Inhibition of FGF signaling dramatically expands the region expressing kctd15. Embryos were treated with indicated doses of SU5402 at stage 9, fixed at stage 15, and then subjected for whole mount in situ hybridization against kctd15. Upper panels show dorsal views with anterior toward the top. Lower panels show lateral views with anterior to the left. White arrowheads indicate unclosed blastopores, which are commonly observed phenotypes caused by inhibition of the FGF pathway (Amaya et al., 1991; Chung et al., 2004).

Gene Clone Species Stages Anatomy
kctd15.L image:5440283 laevis NF stage 16 cranial neural crest , neural crest

  kctd15 (potassium channel tetramerization domain containing 15) gene expression in Xenopus laevis embryo, assayed via in situ hybridization, NF stage 16, lateral view, anterior left, dorsal up.

Gene Clone Species Stages Anatomy
kctd15.L image:5440283 laevis NF stage 25 olfactory placode , mandibular crest , trigeminal placode , trigeminal ganglion , anterodorsal lateral line placode

  kctd15 (potassium channel tetramerization domain containing 15) gene expression in Xenopus laevis embryo, assayed via in situ hybridization, NF stage 25, lateral view, anterior left, dorsal up.